Answers are grounded in this paper and cite their sources.
Fibroblasts cultured from the skin of patients with Sandhoff disease accumulate excessive amounts of sulfated glycosaminoglycans, probably chondroitin sulfate and dermatan sulfate. In addition, Sandhoff fibroblasts show a lengthened turnover time for these compounds. Only little such abnormality in sulfated glycosaminoglycan metabolism has been found in Tay‐Sachs fibroblasts. 2. The impaired catabolism of glycosaminoglycans in Sandhoff fibroblasts can be normalized, i.e. corrected, by addition of β‐N‐acetylhexosaminidase isozyme A from normal human urine to the culture medium. β‐N‐Acetylhexosaminidase isozyme B from urine is ineffective because it is not taken up by the cells. However, if homogenates of normal or Tay‐Sachs fibroblasts are used as a source of the enzymes, metabolic correction is obtained in both instances. When β‐N‐acetylhexosaminidase isozymes A and B of normal fibroblasts are separated by isoelectric focusing and tested individually, isozyme A exhibits about five times the corrective activity of isozyme B, when compared on the basis of their activity toward the synthetic substrate. 3. Although β‐N‐acetylhexosaminidase isozyme B participates in the degradation of sulfated glycosaminoglycans in cultured cells, only fibroblast homogenates containing isozyme A release N‐acetylglucosamine from [14C]glucosamine‐labelled hyaluronic acid oligosaccharides in vitro.
No takes yet. Share an insight, caveat, or question.
Cantz et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: